Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Browse by Series:

Full FDA Approvals in Breast Cancer and Lung Cancer, Priority Reviews in ALL, and More

Brielle Urciuoli
Published: Thursday, Apr 06, 2017



Brielle Urciuoli reports on full FDA approvals in breast cancer and non–small cell lung cancer, priority reviews in acute lymphoblastic leukemia, an ODAC recommendation for hematologic malignancies, a biologics license application submitted in non–Hodgkin lymphoma, a new drug application accepted in graft-versus-host disease, promising phase III results and a European approval in lung cancer.
SELECTED
LANGUAGE
Slider Left
Slider Right


Brielle Urciuoli reports on full FDA approvals in breast cancer and non–small cell lung cancer, priority reviews in acute lymphoblastic leukemia, an ODAC recommendation for hematologic malignancies, a biologics license application submitted in non–Hodgkin lymphoma, a new drug application accepted in graft-versus-host disease, promising phase III results and a European approval in lung cancer.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x